Mortality implications of primary percutaneous coronary intervention treatment delays: Insights from the assessment of pexelizumab in acute myocardial infarction trial

Michael P. Hudson, Paul W. Armstrong, William W. O'Neil, Amanda L. Stebbins, Weaver W. Douglas, Petr Widimsky, Philip E. Aylward, Witold Ruzyllo, David Holmes, Kenneth W. Mahaffey, Christopher B. Granger

Research output: Contribution to journal › Article › peer-review

23 Scopus citations

Fingerprint

Dive into the research topics of 'Mortality implications of primary percutaneous coronary intervention treatment delays: Insights from the assessment of pexelizumab in acute myocardial infarction trial'. Together they form a unique fingerprint.

Medicine & Life Sciences